
Oriental Pharmaceutical Industries Limited
Pharmaceutical company manufacturing and selling various medical and medicinal products since 1941.
Pharmaceutical company manufacturing and selling various medical and medicinal products since 1941.
Oriental Pharmaceutical Industries Limited (OPIL) was founded in India on 11 March 1941 and has a glorious history of 83 years and 11 months.Its registered office is in Kolhapur, Maharashtra, India.
The Corporate was formerly known as The Oriental Pharmaceutical Industries Limited. The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 0.64 M.
The company currently has active open charges totaling ₹50.27 Cr. The company has closed loans amounting to ₹25.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Dhau Lambore, Youhaan Kapadia, and Amol Kapadia serve as directors at the Company.
Kolhapur, Maharashtra, India
+91-XXXXXXXXXX
-
U24239MH1941PLC003286
003286
Public Limited Indian Non-Government Company
11 Mar 1941
29 Sep 2023
31 Mar 2023
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Youhaan Kapadia ![]() | Additional Director | 19-Dec-2023 | Current |
Dhau Lambore ![]() | Director | 13-Feb-2014 | Current |
Amol Kapadia ![]() | Director | 01-Sep-1995 | Current |
Oriental Pharmaceutical Industries Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 10.84% decrease. The company also saw a substantial fall in profitability, with a 130.27% decrease in profit. The company's net worth dipped by a decrease of 1.67%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2022, Oriental Pharmaceutical Industries had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Youhaan Kapadia and Amol Kapadia are mutual person
Dhau Lambore and Amol Kapadia are mutual person
Dhau Lambore and Amol Kapadia are mutual person
Youhaan Kapadia and Amol Kapadia are mutual person
Dhau Lambore, Youhaan Kapadia and 1 more are mutual person
Dhau Lambore, Youhaan Kapadia and 1 more are mutual person
₹502.70 M
₹250.00 M
Date | Lender | Amount | Status |
---|---|---|---|
29 Dec 2017 | Hdfc Bank Limited | ₹23.00 Cr | Open |
10 Nov 2017 | Hdfc Bank Limited | ₹27.27 Cr | Open |
31 Mar 2015 | Kotak Mahindra Bank Limited | ₹25.00 Cr | Satisfied |
Unlock and access historical data on people associated with Oriental Pharmaceutical Industries, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Oriental Pharmaceutical Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oriental Pharmaceutical Industries's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Youhaan Amol Kapadia was appointed as a Additional Director was appointed as a Additional Director on 19 Dec 2023 & has been associated with this company since 1 year 2 months .
19 Dec 2023
Oriental Pharmaceutical Industries Limited last Annual general meeting of members was held on 29 Sep 2023 as per latest MCA records.
29 Sep 2023
Oriental Pharmaceutical Industries Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
31 Mar 2023
A charge with Hdfc Bank Limited of Rs. 272.70 M registered on 10 Nov 2017 with Charge ID 100151793 was modified on 21 Apr 2022.
21 Apr 2022
A charge with Hdfc Bank Limited amounted to Rs. 230.00 M with Charge ID 100159148 was registered on 29 Dec 2017.
29 Dec 2017
A charge with Hdfc Bank Limited amounted to Rs. 272.70 M with Charge ID 100151793 was registered on 10 Nov 2017.
10 Nov 2017
Oriental Pharmaceutical Industries Limited was incorporated on 11 Mar 1941.
The authorized share capital of Oriental Pharmaceutical Industries Limited is ₹ 6.00 M and paid-up capital is ₹ 0.64 M.
Currently 3 directors are associated with Oriental Pharmaceutical Industries Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Oriental Pharmaceutical Industries Limited is Factory Premisesoff Polson Ltd Ambaghat India, Vishalgad, Maharashtra, 415101.
The corporate identification number (CIN) of Oriental Pharmaceutical Industries Limited is U24239MH1941PLC003286 and the company number is 003286 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Oriental Pharmaceutical Industries Limited has fallen by -10.84%.
The financial reports for the fiscal year 2022 indicates that The net worth of Oriental Pharmaceutical Industries Limited has experienced an downturn of -1.67%.
As per the financial statements for fiscal Year 2022, The total open charges for Oriental Pharmaceutical Industries Limited amount to ₹ 50.27 Cr.
The most recent Balance Sheet for Oriental Pharmaceutical Industries Limited was filed with the ROC on 31 Mar 2023.